Genomics ETF Setting Up Nicely for the Long-Term

Genomics is evolving and that evolution confirms an a strong underlying investment thesis, one accessible via the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). Already one of the best-performing healthcare ETFs over the past several years, ARKG is positioned to capitalize on some...